| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/24/2003 | WO2003018612A3 Extracellular messengers |
| 07/24/2003 | WO2003016495A3 Transgenic rodents as animal models for modulation of b1 bradykinin receptor protein |
| 07/24/2003 | WO2003011895A3 Compositions and methods for modulation of immune responses |
| 07/24/2003 | WO2003006688A3 Methods for diagnosis and treatment of diseases associated with altered expression of gnas |
| 07/24/2003 | WO2003006661A3 Transgenic plants expressing cobalamin binding proteins |
| 07/24/2003 | WO2003004526B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines |
| 07/24/2003 | WO2002102994A3 Human secreted proteins |
| 07/24/2003 | WO2002102839A3 Novel g-protein coupled receptors and dna sequences thereof |
| 07/24/2003 | WO2002094873A3 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use |
| 07/24/2003 | WO2002088358A3 Human fibroblast growth factor-related compositions |
| 07/24/2003 | WO2002088310A3 Cobra gene and uses thereof |
| 07/24/2003 | WO2002079439A3 TRANSGENIC MICE CONTAINING mGluR7 METABOTROPIC GLUTAMATE RECEPTOR GENE DISRUPTIONS |
| 07/24/2003 | WO2002077156A3 Protection-of-telomere-1 (pot-1) protein and encoding polynucleotides |
| 07/24/2003 | WO2002077011A3 Oxidation-reduction sensitive green fluorescent protein variants |
| 07/24/2003 | WO2002074807A3 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 07/24/2003 | WO2002072765A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 07/24/2003 | WO2002070645A3 Functional surface display of polypeptides |
| 07/24/2003 | WO2002066640A3 Zinc finger binding domains for nucleotide sequence ann |
| 07/24/2003 | WO2002062846A3 Method and apparatus for the production of antigens and uses thereof |
| 07/24/2003 | WO2002060942A3 Protein modification and maintenance molecules |
| 07/24/2003 | WO2002056028A3 Ingap displacement assays |
| 07/24/2003 | WO2002055550A3 Crystallization and structure determination of fema and/or fema-like proteins |
| 07/24/2003 | WO2002055534A3 Haplotypes of the f2rli gene |
| 07/24/2003 | WO2002053770A3 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/24/2003 | WO2002053719A3 Cytoskeleton-associated proteins |
| 07/24/2003 | WO2002051979A3 Method to remove citrate and aluminum from proteins |
| 07/24/2003 | WO2002050278A3 Novel human secreted proteins and polynucleotides encoding the same |
| 07/24/2003 | WO2002050276A3 Proteins and nucleic acids encoding same |
| 07/24/2003 | WO2002050275A3 Proteins and nucleic acids encoding same |
| 07/24/2003 | WO2002036634A3 Gene regulation therapy involving ferritin |
| 07/24/2003 | WO2002033087A3 Proteins and nucleic acids encoding same |
| 07/24/2003 | WO2002022687A3 Viral chemokine-tumur antigen fusion proteins |
| 07/24/2003 | WO2002018954A3 Inhibition of cmv infection and dissemination |
| 07/24/2003 | WO2002006537A3 Methods of identifying renal protective factors |
| 07/24/2003 | WO2001091548A3 Mice heterozygous for wfs1 gene as mouse models for depression |
| 07/24/2003 | WO2001079447A8 Novel bone marrow nucleic acids and polypeptides |
| 07/24/2003 | US20030140381 Genes and regulatory DNA sequences associated with stress-related gene expression in plants and methods of using the same |
| 07/24/2003 | US20030140379 Novel DNA sequences in plant Caragana jubata with freeze tolerance and a method thereof |
| 07/24/2003 | US20030140378 Antirrhinum majus/arabidopsis nucleotide sequences coding and expressing centroradialis (CEN)/terminal flower-1 (TF1) genes in apical meristems; controlling fruit propagation; papermaking |
| 07/24/2003 | US20030140377 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 07/24/2003 | US20030140375 Nucleotide sequences coding R-resistant genes/proteins for generating disease resistant plants; animal feeds |
| 07/24/2003 | US20030140371 Using pesticide to disrupt organic solute transporter/ligand-gated ion channel protein (CAATCH); biological pest control; amino acid-based targeted pesticides |
| 07/24/2003 | US20030140369 Nucleotide sequences coding proteins for improving disease resistance or tolerance in crop plants |
| 07/24/2003 | US20030140368 Plant defensins |
| 07/24/2003 | US20030140363 Expression vector comprising hydrolase regulatory sequences, matrix attachment region (MAR) and transcriptional enhancer for use as gene transfer tools |
| 07/24/2003 | US20030140361 CCR6 chemokine receptor disruptions, compositions and methods relating thereto |
| 07/24/2003 | US20030140359 Non-human mammals comprising cells expressing vector-borne rat PTTG carboxy-terminal-related DNA |
| 07/24/2003 | US20030140358 Transgenic mammal coding serine protease inhibitor which is expressed in mammary gland tissue and products for treating immunosuppression disorders and angioedema |
| 07/24/2003 | US20030140357 Transgenic mammal coding cholesteryl ester transfer protein and exhibiting atherosclerotic phenotype for use in treatment and diagnosis of cardiovascular and hypertensive disorders |
| 07/24/2003 | US20030140356 Mimetic of functional transforming growth factor/myostatin (MSTN 350); for increasing/inhibiting muscle growth in animals; veterinary medicine; antiproliferative/anticarcinogeneic agents |
| 07/24/2003 | US20030140355 Expression vector containing lectin gene regulation site of mud loach |
| 07/24/2003 | US20030139591 Isolation and use of tissue growth-inducing Frzb protein |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139589 G protein coupled receptor A4 |
| 07/24/2003 | US20030139588 Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 07/24/2003 | US20030139587 Novel human proteins and polynucleotides encoding the same |
| 07/24/2003 | US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents |
| 07/24/2003 | US20030139582 Composition containing biologically active polypeptides suitable for the oral administration |
| 07/24/2003 | US20030139581 Protocadherin materials and methods |
| 07/24/2003 | US20030139576 Cell growth factor for stimulating proliferation/diffrentiation of chrondrocytes and treatment of bone disorders; anticarcinogenic/antiinflammatory agents |
| 07/24/2003 | US20030139575 Cytokine immunoconjugates |
| 07/24/2003 | US20030139574 Active hedgehog protein conjugate |
| 07/24/2003 | US20030139573 Lipid binding protein 3 |
| 07/24/2003 | US20030139572 Novel compounds |
| 07/24/2003 | US20030139571 G protein-coupled chemokine receptor for prevention and detection of viral infection; viricides |
| 07/24/2003 | US20030139365 Expression and export of angiogenesis inhibitors as immunofusins |
| 07/24/2003 | US20030139358 Anticancer agents; genetic engineering |
| 07/24/2003 | US20030139348 Animal growth regulators |
| 07/24/2003 | US20030139344 Apoptosis gene; anticancer agents; ovaries |
| 07/24/2003 | US20030139343 Regulation of human hm74-like g protein coupled receptor |
| 07/24/2003 | US20030139341 Regulation of human lgr4-like g protein -coupled receptor |
| 07/24/2003 | US20030139330 Transcription factors containing two potential dna binding motifs |
| 07/24/2003 | US20030139329 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030139328 Complexing; modulating biological activation |
| 07/24/2003 | US20030139327 Nucleic acids, proteins, and antibodies |
| 07/24/2003 | US20030139324 Cancer diagnosis, therapy; genetic engineered polypeptide |
| 07/24/2003 | US20030138972 Monoclonal antibodies specific PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 07/24/2003 | US20030138966 Dissolving the samples containing hydrophobic protein, protein fragemnt, modification and peptides to be investigated in an organic medium, subjecting them to thin- layer chromatography and detecting the hydrophobic proteins |
| 07/24/2003 | US20030138955 Delivering nucleotide sequences coding myogenin protein for improving angiogenesis and/or neovascularisation; skin grafting; tissue engineering; wound healing agents; gene therapy |
| 07/24/2003 | US20030138946 Genetically engineered major histocompatibiity complex antigen presenting cells for activating CD8 lymphocytes and producing cytokines and becoming cytotoxic; antitumor agents |
| 07/24/2003 | US20030138932 Comprises enzymatic glycoproteins for use as antitumor/antiproliferative agents; enzyme inhibitors; drug screening |
| 07/24/2003 | US20030138926 Novel polynucleotides and polypeptides encoded thereby |
| 07/24/2003 | US20030138925 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 07/24/2003 | US20030138916 Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
| 07/24/2003 | US20030138915 Apotosis-2 ligand receptor/tumor necrosis factor for detecting modulator of apoptosis; drug screening; treating nervous system and liver disorders; antiproliferative agents |
| 07/24/2003 | US20030138914 Factor X deletion mutants and analogues thereof |
| 07/24/2003 | US20030138913 Haemostatically active preparation containing vwf and method for the production thereof |
| 07/24/2003 | US20030138912 EGF-like nucleic acids |
| 07/24/2003 | US20030138911 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 07/24/2003 | US20030138910 Incubating blood for in vitro (syringe) induction of modulators to cytokine binding membrane protein; antiarthritic agents |
| 07/24/2003 | US20030138908 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 07/24/2003 | US20030138907 Preparing and recovering a genetically engineered muscle protein by protecting sulfhydryl groups (reaction with sodium tetrathionate) and isolation by anion exchange chromatography and hydrophobic interaction chromatography |
| 07/24/2003 | US20030138905 Compositions isolated from bovine mammary gland and methods for their use |
| 07/24/2003 | US20030138904 Pro-polypeptide membrane protein for stimulating/inhibiting proliferation/differentiation of chrondrocytes and/or endothelial cells; neovascularization; tumor diagnosis |
| 07/24/2003 | US20030138903 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138902 Pro-polypeptide membrane protein for stimulating/inhibiting proliferation/differentiation of chrondrocytes and/or endothelial cells; neovascularization; tumor diagnosis |
| 07/24/2003 | US20030138901 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138900 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138899 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138898 Secreted and transmembrane polypeptides and nucleic acids encoding the same |